Stockreport

Opus Genetics Announces $23 Million Registered Direct Offering

Opus Genetics, Inc.  (IRD) 
PDF - Financing led by Perceptive Advisors and Balyasny Asset Management - - Proceeds targeted to fund rapid development of ophthalmic gene therapy clinical programs - RES [Read more]